Advanced Science · 2024 · 25 citations · 30 references
Life SciencesImmunologyOncologyImmunotherapyTumor ImmunologyTumor MicroenvironmentAdjuvant ImmunotherapyCancer ImmunotherapyCancer NanomedicineHydrogelsNanomedicineTumor Immune MicroenvironmentAntitumor Immune ActivationDna Double HelixHydrogel MaterialsIntratumoral AdministrationReactive Oxygen Species GenerationReactive Oxygen Species-responsive HydrogelsTumor Microenvironment ResponsivenessTumor Microenvironment-responsive Targeting
Abstract Chemodynamic therapy (CDT) shows immense potential in cancer treatment as it not only directly kills tumor cells but also induces anti‐tumor immune responses. However, the efficacy of CDT is hampered by challenges in targeting CDT catalysts specifically to tumors using nanomaterials, along with the limitations of low H 2 O 2 levels and short catalyst duration within the tumor microenvironment. In this study, DNA adjuvant hydrogel to arrange a glucose oxidase‐ferrocene cascade for continuously generating reactive oxygen species (ROS) from glucose in situ for tumor CDT combined with immunotherapy is employed. By precisely tuning the catalyst spacing with DNA double helix, ROS production efficiency is elevated by up to nine times compared to free catalysts, resulting in stronger immunogenetic cell death. Upon intratumoral injection, the DNA hydrogel system elicited potent anti‐tumor immune responses, thereby effectively inhibiting established tumors and rejecting re‐challenged tumors. This work offers a novel platform for integrated CDT and immunotherapy in cancer treatment.
30
Tumor-selective catalytic nanomedicine by nanocatalyst delivery
Minfeng Huo, Liying Wang, Yu Chen et al. · Nature Communications · 2017 · 1.3K citations · Full text
Recent progress of chemodynamic therapy-induced combination cancer therapy
Xianwen Wang, Xianyan Zhong, Zhuang Liu et al. · Nano Today · 2020 · 706 citations
Medicine, Oncology, Pharmacology +14
Antigen-capturing nanoparticles improve the abscopal effect and cancer immunotherapy
Yuanzeng Min, Kyle C. Roche, Shaomin Tian et al. · Nature Nanotechnology · 2017 · 689 citations
Life Sciences, Immunology, Oncology +16
Lu Zhang, Shuangshuang Wan, Chu‐Xin Li et al. · Nano Letters · 2018 · 586 citations